ArticleCurrent treatment options in oncology2022

Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies.

Jingqin Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.